{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:07:11Z","timestamp":1780106831167,"version":"3.54.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"My Blue Dots Fund"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.adro.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T13:45:45Z","timestamp":1527169545000},"page":"621-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3012-7021","authenticated-orcid":false,"given":"Diego A.S.","family":"Toesca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Koong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"von Eyben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Koong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2018.05.006_bib0010","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1200\/JCO.1994.12.10.2229","article-title":"Karnofsky Memorial lecture. Natural history of small breast cancers","volume":"12","author":"Hellman","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","article-title":"Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases","volume":"113","author":"Pastorino","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.adro.2018.05.006_bib0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00000658-198405000-00002","article-title":"The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment","volume":"199","author":"Wagner","year":"1984","journal-title":"Ann Surg"},{"key":"10.1016\/j.adro.2018.05.006_bib0030","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I","article-title":"Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Fran\u00e7aise de Chirurgie","volume":"77","author":"Nordlinger","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2018.05.006_bib0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.0300-0664.2001.01435.x","article-title":"Metastatic tumours of the adrenal glands: A 30-year experience in a teaching hospital","volume":"56","author":"Lam","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.adro.2018.05.006_bib0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7","article-title":"Metastases in carcinoma: Analysis of 1000 autopsied cases","volume":"3","author":"Abrams","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2018.05.006_bib0045","first-page":"1795","article-title":"18F-FDG PET in characterizing adrenal lesions detected on CT or MRI","volume":"42","author":"Yun","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.adro.2018.05.006_bib0050","first-page":"2058","article-title":"18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer","volume":"45","author":"Kumar","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.adro.2018.05.006_bib0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MNM.0b013e32834199e7","article-title":"The role of fluorodeoxyglucose-positron emission tomography\/computed tomography in differentiating between benign and malignant adrenal lesions","volume":"32","author":"Ozcan Kara","year":"2011","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.adro.2018.05.006_bib0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/EJE-15-0707","article-title":"18F-FDG PET\/CT in the post-operative monitoring of patients with adrenocortical carcinoma","volume":"173","author":"Ardito","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.adro.2018.05.006_bib0065","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/bjs.1800830432","article-title":"Adrenalectomy for metastatic disease to the adrenal glands","volume":"83","author":"Lo","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/j.adro.2018.05.006_bib0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9610(97)00281-X","article-title":"A comparison of adrenalectomy with other resections for metastatic cancers","volume":"175","author":"Wade","year":"1998","journal-title":"Am J Surg"},{"key":"10.1016\/j.adro.2018.05.006_bib0075","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10434-999-0633-z","article-title":"Long-term survival after complete resection of melanoma metastatic to the adrenal gland","volume":"6","author":"Haigh","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0080","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0003-4975(00)02509-1","article-title":"Resection of adrenal metastases from non-small cell lung cancer: A multicenter study","volume":"71","author":"Porte","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.adro.2018.05.006_bib0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jtcvs.2004.09.020","article-title":"Surgical treatment of solitary adrenal metastasis from non-small cell lung cancer","volume":"130","author":"Mercier","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.adro.2018.05.006_bib0090","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1245\/s10434-007-9520-7","article-title":"Laparoscopic adrenalectomy for isolated adrenal metastasis","volume":"14","author":"Strong","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jso.21293","article-title":"Should we use laparoscopic adrenalectomy for metastases? Scandinavian multicenter study","volume":"100","author":"Marangos","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejso.2010.04.002","article-title":"Prognostic factors for survival after surgery for adrenal metastasis","volume":"36","author":"Muth","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0105","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s00268-012-1506-3","article-title":"Adrenalectomy improves outcomes of selected patients with metastatic carcinoma","volume":"36","author":"Vazquez","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.adro.2018.05.006_bib0110","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1245\/s10434-012-2464-6","article-title":"Renal origin and size are independent predictors of survival after surgery for adrenal metastasis","volume":"19","author":"Zerrweck","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0115","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1245\/s10434-013-3050-2","article-title":"Outcome and prognostic factors after adrenalectomy for patients with distant adrenal metastasis","volume":"20","author":"Howell","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0120","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.surg.2013.06.021","article-title":"Adrenalectomy for solid tumor metastases: Results of a multicenter European study","volume":"154","author":"Moreno","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.adro.2018.05.006_bib0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1148\/radiol.2311031007","article-title":"Adrenal neoplasms: CT-guided radiofrequency ablation\u2013preliminary results","volume":"231","author":"Mayo-Smith","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.adro.2018.05.006_bib0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2214\/AJR.07.2145","article-title":"CT-guided percutaneous chemical ablation of adrenal neoplasms","volume":"190","author":"Xiao","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.adro.2018.05.006_bib0135","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.ejrad.2011.04.054","article-title":"Adrenal neoplasms: Effectiveness and safety of CT-guided ablation of 23 tumors in 22 patients","volume":"81","author":"Wolf","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.adro.2018.05.006_bib0140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jvir.2013.12.013","article-title":"A single-institution experience in image-guided thermal ablation of adrenal gland metastases","volume":"25","author":"Welch","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.adro.2018.05.006_bib0145","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1148\/radiol.2015142029","article-title":"Unresectable adrenal metastases: Clinical outcomes of radiofrequency ablation","volume":"277","author":"Hasegawa","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.adro.2018.05.006_bib0150","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3348\/kjr.2016.17.6.864","article-title":"Short-term outcomes and safety of computed tomography-guided percutaneous microwave ablation of solitary adrenal metastasis from lung cancer: A multi-center retrospective study","volume":"17","author":"Men","year":"2016","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.adro.2018.05.006_bib0155","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/02656736.2016.1164905","article-title":"Percutaneous microwave ablation of adrenal tumours under ultrasound guidance in 33 patients with 35 tumours: A single-centre experience","volume":"32","author":"Ren","year":"2016","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.adro.2018.05.006_bib0160","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jvir.2017.07.026","article-title":"Local control and survival after image-guided percutaneous ablation of adrenal metastases","volume":"29","author":"Frenk","year":"2018","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.adro.2018.05.006_bib0165","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4103\/0366-6999.210496","article-title":"Thermal ablation in the management of adrenal metastasis originating from non-small cell lung cancer: A 5-year single-center experience","volume":"130","author":"Botsa","year":"2017","journal-title":"Chin Med J"},{"key":"10.1016\/j.adro.2018.05.006_bib0170","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-15-0822","article-title":"New strategies in stereotactic radiotherapy for oligometastases","volume":"21","author":"Palma","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adro.2018.05.006_bib0175","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1002\/cncr.26611","article-title":"Stereotactic body radiotherapy for multisite extracranial oligometastases: Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease","volume":"118","author":"Salama","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2018.05.006_bib0180","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/cncr.23209","article-title":"A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions","volume":"112","author":"Milano","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2018.05.006_bib0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2008.10.079","article-title":"Stereotactic body radiotherapy for treatment of adrenal metastases","volume":"75","author":"Chawla","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.05.006_bib0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/COC.0b013e3181dbb727","article-title":"Role of radiotherapy for local control of asymptomatic adrenal metastasis from lung cancer","volume":"34","author":"Oshiro","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00066-011-2192-z","article-title":"Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer","volume":"187","author":"Holy","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2018.05.006_bib0200","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ijrobp.2010.11.060","article-title":"Stereotactic radiotherapy for adrenal gland metastases: University of Florence experience","volume":"82","author":"Casamassima","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.05.006_bib0205","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/0284186X.2011.652738","article-title":"Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: A retrospective analysis of 34 patients","volume":"51","author":"Scorsetti","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0210","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/COC.0b013e3182569189","article-title":"Stereotactic body radiotherapy in the treatment of adrenal metastases","volume":"36","author":"Ahmed","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0215","article-title":"Treating adrenal tumors in 26 patients with CyberKnife: A mono-institutional experience","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.adro.2018.05.006_bib0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7785\/tcrt.2012.500320","article-title":"Stereotactic body radiation therapy for curative treatment of adrenal metastases","volume":"12","author":"Rudra","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.adro.2018.05.006_bib0225","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5301\/tj.5000222","article-title":"Evaluation of stereotactic body radiation therapy in the management of adrenal metastases from non-small cell lung cancer","volume":"101","author":"Gamsiz","year":"2015","journal-title":"Tumori"},{"key":"10.1016\/j.adro.2018.05.006_bib0230","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4143\/crt.2016.057","article-title":"Minimally invasive stereotactical radio-ablation of adrenal metastases as an alternative to surgery","volume":"49","author":"Franzese","year":"2017","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.adro.2018.05.006_bib0235","first-page":"e1120","article-title":"Robotic radiosurgery for adrenal gland metastases","volume":"9","author":"Haidenberger","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.adro.2018.05.006_bib0240","first-page":"5285","article-title":"Robot-assisted extracranial stereotactic radiotherapy of adrenal metastases in oligometastatic non-small cell lung cancer","volume":"37","author":"Celik","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.adro.2018.05.006_bib0245","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.prro.2016.09.005","article-title":"Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity","volume":"7","author":"Chance","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0250","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1016\/j.ijrobp.2012.03.006","article-title":"Intrafraction verification of gated RapidArc by using beam-level kilovoltage X-ray images","volume":"83","author":"Li","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.05.006_bib0255","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0360-3016(01)02822-X","article-title":"The effectiveness of breath-holding to stabilize lung and pancreas tumors during radiosurgery","volume":"53","author":"Murphy","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.05.006_bib0260","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/COC.0b013e31818da9e0","article-title":"Pancreatic tumor motion on a single planning 4D-CT does not correlate with intrafraction tumor motion during treatment","volume":"32","author":"Minn","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0265","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03","author":"National Institutes of Health","year":"2010"},{"key":"10.1016\/j.adro.2018.05.006_bib0270","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.adro.2018.05.006_bib0275","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.adro.2018.05.006_bib0280","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0360-3016(87)90297-5","article-title":"Repair of sublethal radiation injury after multiple small doses in mouse kidney: An estimate of flexure dose","volume":"13","author":"Stewart","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.05.006_bib0285","series-title":"Basic Clinical Radiobiology","first-page":"102","article-title":"Fractionation: The linear-quadratic approach","author":"Joiner","year":"2009"},{"key":"10.1016\/j.adro.2018.05.006_bib0290","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0360-3016(01)01599-1","article-title":"Extent and kinetics of recovery of occult spinal cord injury","volume":"50","author":"Ang","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.05.006_bib0295","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0360-3016(96)00453-1","article-title":"Long-term recovery kinetics of radiation damage in rat spinal cord","volume":"37","author":"Wong","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.05.006_bib0300","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2018.05.006_bib0305","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.adro.2018.05.006_bib0310","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1245\/s10434-014-3750-2","article-title":"Factors associated with higher risk of complications after adrenal surgery","volume":"22","author":"Hauch","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0315","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jvir.2015.11.034","article-title":"Catecholamine surge during image-guided ablation of adrenal gland metastases: Predictors, consequences, and recommendations for management","volume":"27","author":"Fintelmann","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.adro.2018.05.006_bib0320","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4158\/EP161498.OR","article-title":"Image-guided thermal ablation of adrenal metastases: Hemodynamic and endocrine outcomes","volume":"23","author":"Espinosa de Ycaza","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/j.adro.2018.05.006_bib0325","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.prro.2011.11.002","article-title":"Preservation of adrenal function after successful stereotactic body radiation therapy of metastatic renal cell carcinoma involving the remaining contralateral adrenal gland","volume":"2","author":"Eldaya","year":"2012","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0330","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.radonc.2016.01.027","article-title":"Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship","volume":"118","author":"Siva","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0335","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13014-017-0798-8","article-title":"Quantification of renal function following stereotactic body radiotherapy for pancreatic cancer: Secondary dosimetric analysis of a prospective clinical trial","volume":"12","author":"Verma","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0340","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13014-014-0253-z","article-title":"Short communication: Timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial (99m)Tc-DMSA SPECT\/CT","volume":"9","author":"Jackson","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0345","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13014-016-0651-5","article-title":"Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma","volume":"11","author":"Yamamoto","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2018.05.006_bib0350","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000469669","article-title":"Serum creatinine: Not so simple!","volume":"136","author":"Delanaye","year":"2017","journal-title":"Nephron"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109418300848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109418300848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:36:36Z","timestamp":1762529796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109418300848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2452109418300848"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2018.05.006","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}